Drug
Hydrochlorothiazide
Hydrochlorothiazide: highest development phase Approved, developed by LEO Pharma, Merck, Novartis and others. 6 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- LEO Pharma, Merck, Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| HYDROCHLOROTHIAZIDE W/ RESERPINE | Approved | |
| ESIDRIX | Approved | |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Approved | |
| IRBESARTAN AND HYDROCHLOROTHIAZIDE | Approved | |
| TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Approved | |
| TIMOLIDE 10-25 | Approved |
Latest
- Label updated: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
- Label updated: TRIAMTERENE AND HYDROCHLOROTHIAZIDE
Follow Hydrochlorothiazide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.